Artificial Intelligence and Uterine Fibroids: A Useful Combination for Diagnosis and Treatment
- PMID: 40429449
- PMCID: PMC12112542
- DOI: 10.3390/jcm14103454
Artificial Intelligence and Uterine Fibroids: A Useful Combination for Diagnosis and Treatment
Abstract
This manuscript examines the role of artificial intelligence (AI) in the diagnosis and treatment of uterine fibroids and uterine sarcomas, offering a comprehensive assessment of AI-supported diagnostic and therapeutic techniques. Through the use of radiomics, machine learning, and deep neural network models, AI shows promise in identifying benign and malignant uterine lesions, directing therapeutic decisions, and improving diagnostic accuracy. It also demonstrates significant capabilities in the timely detection of fibroids. Additionally, AI improves surgical precision, real-time structure detection, and patient outcomes by transforming surgical techniques such as myomectomy, robot-assisted laparoscopic surgery, and High-Intensity Focused Ultrasound (HIFU) ablation. By helping to forecast treatment outcomes and monitor progress during procedures like uterine fibroid embolization, AI also offers a fresh and fascinating perspective for improving the clinical management of these conditions. This review critically assesses the current literature, identifies the advantages and limitations of various AI approaches, and provides future directions for research and clinical implementation.
Keywords: artificial intelligence; deep neural network; high-intensity focused ultrasound; machine learning; magnetic resonance imaging; myoma; uterine fibroids; uterine leiomyosarcoma.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
References
Publication types
LinkOut - more resources
Full Text Sources
